AssayRouter: Historical Utility Priors for Frozen Molecular Predictor Routing
Abstract
Laboratories often face a new molecular assay with 16-64 labels and a bank of predictors whose training data and parameters are unavailable. The practical question is which frozen outputs to include in a small local model. AssayRouter treats completed assays as pseudo-targets and labels each candidate by its post-fit utility: the reduction in held-out discovery loss when the candidate is added to the local target predictor. A shared regressor learns to predict this utility from candidate behavio...
Description / Details
Laboratories often face a new molecular assay with 16-64 labels and a bank of predictors whose training data and parameters are unavailable. The practical question is which frozen outputs to include in a small local model. AssayRouter treats completed assays as pseudo-targets and labels each candidate by its post-fit utility: the reduction in held-out discovery loss when the candidate is added to the local target predictor. A shared regressor learns to predict this utility from candidate behavior on the support set, without source identity; on a new assay, one frozen ranking selects four sources and separate labels fit a convex combiner. We train only on completed ChEMBL-MT assays and evaluate 24 external regression assays across six frozen interface families. AssayRouter-C lowers strict four-call negative log-likelihood (NLL) by 0.0409 relative to Support-CV@4. Frozen candidate-label permutations confirm that candidate-utility correspondence carries the transferred information, and leave-one-interface-out training shows that the mapping generalizes to unseen predictor families. Completed assays therefore provide transferable supervision for scarce-label routing through frozen prediction interfaces.
Source: arXiv:2609.37285v1 - http://arxiv.org/abs/2609.37285v1 PDF: https://arxiv.org/pdf/2609.37285v1 Original Link: http://arxiv.org/abs/2609.37285v1
Please sign in to join the discussion.
No comments yet. Be the first to share your thoughts!
Sep 30, 2026
Pharmaceutical Research
Biochemistry
0